Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct;26(10):1146-1155.
doi: 10.1111/jvh.13126. Epub 2019 Jun 19.

Roadmap to functional cure of chronic hepatitis B: An expert consensus

Qin Ning  1 , Di Wu  1 , Gui-Qiang Wang  2 , Hong Ren  3 , Zhi-Liang Gao  4 , Peng Hu  3 , Mei-Fang Han  1 , Yan Wang  2 , Wen-Hong Zhang  5 , Feng-Min Lu  6 , Fu-Sheng Wang  7
Affiliations
Review

Roadmap to functional cure of chronic hepatitis B: An expert consensus

Qin Ning et al. J Viral Hepat. 2019 Oct.

Abstract

Hepatitis B virus (HBV) infection continues to be a major public health issue worldwide. HBsAg loss is associated with functional remission and improved long-term outcome, and is considered to be a 'functional cure' (also referred to as clinical or immunologic cure) for chronic hepatitis B. This ideal goal of therapy can be achieved using optimized combination regimens with direct-acting antivirals [eg nucleos(t)ide analogues (NAs)] and immunomodulators [eg pegylated interferon alpha2a (Peg-IFN)] in selected patients with chronic hepatitis B. Among different combination therapies currently available, those with NA lead-in followed by Peg-IFN in virally suppressed patients has been demonstrated to be effective. This review provides an updated overview of the evidence supporting the use of combination therapies and summarizes expert consensus on the roadmap to attain functional cure for chronic hepatitis B patients.

Keywords: HBsAg loss; chronic hepatitis B; combination therapy; consensus; functional cure.

PubMed Disclaimer

References

REFERENCES

    1. Schweitzer A, Horn J, Mikolajczyk RT, Krause G, Ott JJ. Estimations of worldwide prevalence of chronic hepatitis B virus infection: a systematic review of data published between 1965 and 2013. Lancet. 2015;386:1546-1555.
    1. World Health Organization. Global Hepatitis Report 2017. World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO.
    1. Sarin SK, Kumar M, Lau GK, et al. Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update. Hepatol Int. 2016;10:1-98.
    1. Terrault NA, Lok A, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560-1599.
    1. European Association for the Study of the Liver. Electronic address eee, European Association for the Study of the L. EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection. J Hepatol 2017;67:370-398.

Publication types

MeSH terms

LinkOut - more resources